Evidence map›Paper›PMID 27742444›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2017

Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.

Juyoung Park, Muna Aryal, Natalia Vykhodtseva, Yong-Zhi Zhang, Nathan McDannold

2 registry-linked trialsAbstract read
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 84 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 1 pooled it
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06330337 phase3recruitingnot on this mapstarted 2024, after this paper: background citation

Specific Model Electroacupuncture Stimulation Promotes Paclitaxel Delivery Across the BBB for Postoperative Glioma Patients: A Randomized Controlled Study

TypeinterventionalSponsorThe Third Affiliated hospital of Zhejiang Chinese Medical UniversityRan2024 to 2027Enrolled58ConditionsGliomaArmsTemozolomide(TMZ) injection or oral administration, Albumin-Bound Paclitaxel(ABX) intravenous drip, Specific mode electroacupuncture stimulation(SMES) intervention
NCT06818331 phase2recruitingnot on this mapstarted 2025, after this paper: background citation

Evaluation of Clinical Efficacy and Safety of Specific Mode Electroacupuncture Stimulation for Paclitaxel Across BBB Delivery in Patients With Postoperative Recurrence of Malignant Glioma: A Single-arm Trial

TypeinterventionalSponsorThe Third Affiliated hospital of Zhejiang Chinese Medical UniversityRan2025 to 2028Enrolled20ConditionsGliomaArmsSMES+PTX, Paclitaxel, Specific mode electroacupuncture stimulation
3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 1 synthesis or guideline pooled it, 173 citations in OpenAlex.

  1. Pooled it
  2. Pharmacokinetic Analysis of Carboplatin and Fluorescein Brain Retention following Ultrasound-Based Blood-Brain Barrier Opening.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Trial
  3. Focused ultrasound for brain metastases.Neuro-oncology advances · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Biological profile of breast cancer brain metastasis.Acta neuropathologica communications · 2025
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Juyoung ParkMedical Device Development Center, Daegu-Gyeongbuk, Medical Innovation Foundation, Daegu, Republic of Korea.
Muna AryalDepartment of Radiology, Brigham & Women's Hospital, Harvard, Medical School, USA. Electronic address: muna@bwh.harvard.edu.
Natalia VykhodtsevaDepartment of Radiology, Brigham & Women's Hospital, Harvard, Medical School, USA.
Yong-Zhi ZhangDepartment of Radiology, Brigham & Women's Hospital, Harvard, Medical School, USA.
Nathan McDannoldDepartment of Radiology, Brigham & Women's Hospital, Harvard, Medical School, USA.
Brigham and Women's Hospital · USDaegu-Gyeongbuk Medical Innovation Foundation · KRHarvard University · US

Funding

Ultrasound-induced blood-brain/tumor barrier disruption in brain metastasesP01CA174645 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI JOLESZ, FERENC A, MCDANNOLD, NATHAN J. · 2013 to 2017
$6.2M
NCI NIH HHS P01 CA174645
6 · The paper itself

Abstract

Drug delivery in brain tumors is challenging because of the presence of blood-brain barrier (BBB) and the blood-tumor barrier (BTB). Focused ultrasound (FUS) combined with microbubbles can enhance the permeability of the BTB in brain tumors, as well as disrupting the BBB in the surrounding tissue. In this study, dynamic contrast-enhanced Magnetic Resonance Imaging (DCE-MRI) was used to characterize FUS-induced permeability changes in a rat glioma model and in the normal brain and to investigate the relationship between these changes and the resulting concentration of the chemotherapy agent doxorubicin (DOX). 9L gliosarcoma cells were implanted in both hemispheres in male rats. At day 10-12 after implantation, FUS-induced BTB disruption using 690kHz ultrasound and Definity microbubbles was performed in one of the tumors and in a normal brain region in each animal. After FUS, DOX was administered at a dose of 5.67mg/kg. The resulting DOX concentration was measured via fluorometry at 1 or 24h after FUS. The transfer coefficient K

Indexed as

AnimalsAntineoplastic AgentsBlood-Brain BarrierBrain NeoplasmsCell Line, TumorContrast MediaDelayed-Action PreparationsDoxorubicinDrug Delivery SystemsDrug LiberationGadolinium DTPAGliosarcomaHumansMaleMicrobubblesPermeabilityAntineoplastic AgentsContrast MediaDelayed-Action PreparationsDoxorubicinGadolinium DTPABlood-brain barrier disruptionDynamic contrast enhance MRIFocused ultrasoundPharmacokinetic model

Identifiers

PMID27742444
PMCPMC5384106
OpenAlexW2531640839

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.